About Midatech Pharma
Midatech Pharma is a Healthcare company based in Raleigh (United States) founded in 2000, and was acquired by Barings in September 2018. Pharmaceuticals for cancer treatment are developed using nanomedicine. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its competitors include C4 Therapeutics, Erasca and MiRagen; 3 of its 3 listed competitors have raised funding.
Company details
Midatech Pharma was founded in 2000 and is headquartered in Raleigh, United States. Operations center on the research and development of pharmaceutical products in oncology, with emphasis on nanomedicine and sustained-release technologies for supportive care. Five products are marketed within the portfolio, targeting cancer treatment applications in the biopharmaceutical sector.
- Headquarters Raleigh, United States
- Stage Acquired
- SectorsHealthcare
- Website midatechpharmaus.com
- Acquired by Barings (Sep 2018)
Investors in Midatech Pharma
Midatech Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Barings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private fund focused on debt and equity investments in real estate and multiple sectors | 1762 | barings.com | London, United Kingdom |
Investor details for Midatech Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Midatech Pharma
2 dated milestones of Midatech Pharma across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Midatech Pharma is founded.
- Exit Acquired by Barings.
Competitors of Midatech Pharma
Midatech Pharma has 3 listed competitors in our database, 3 of them funded. They include C4 Therapeutics, Erasca and MiRagen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. |
Detailed competitors of Midatech Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Midatech Pharma (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Midatech Pharma
Complete news archive for Midatech Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Midatech Pharma
Midatech Pharma was founded in 2000.
Midatech Pharma is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Midatech Pharma was founded in 2000 and is headquartered in Raleigh, United States. Operations center on the research and development of pharmaceutical products in oncology, with emphasis on nanomedicine and sustained-release technologies for supportive care. Five products are marketed within the portfolio, targeting cancer treatment applications in the biopharmaceutical sector.
Midatech Pharma's top competitors include C4 Therapeutics, Erasca and MiRagen.
Midatech Pharma has 1 investor. Key investors include Barings.
Yes. Midatech Pharma was acquired by Barings in September 2018.